Molecule intelOpportunity: ModerateEssential

Triamcinolone

45 brands · 31 companies · product forms

ATC: A01AC01, C05AA12, D07AB09, D07XB02, H02AB08, R01AD11, R03BA06, S01BA05

Opportunity snapshot

Launch attractiveness
39
Market saturation
79
Price room
100
Regulatory risk
0
45
brands
31
companies
Rs 142.98
median price
11
price points
7.61x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 11%

Price room

Across observed sources and strengths
CheapestRs 51.99
MedianRs 142.98
Most expensiveRs 395.62
Spread7.61×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 7.61x across 11 trusted points (Rs 51.99-395.62). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Triamcinolone — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(21) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

31 canonical companies and 45 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 7.61x across 11 trusted points (Rs 51.99-395.62). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.